On Thursday, in the course of Afternoon trade, Shares of Kandi Technologies Group Inc (NASDAQ:KNDI), dropped -3.49%, and is now trading at $7.46.
Kandi Technologies Group declared that Kandi Electric Vehicles Group Co., Ltd. the manufacturer of Kandi Brand electric vehicles received a prepayment of RMB 364.5 million (about US$59.6 million) on August 10, representing a national subsidy for pure EV sales in 2015. The JV Company is a 50/50 joint venture between Kandi and Geely Automobile.
Mr. Hu Xiaoming, Chairman, and Chief Executive Officer of Kandi, commented, “The prepaid national subsidy for pure EV sales in 2015 represents the government’s strong support for the development of the pure EV industry. Kandi’s EVs will continue to rapidly expand as a result of these policies and the overall fast growing market. We are confident we will continue to lead this market and achieve our full year sales target.”
Kandi Technologies Group, Inc., through its auxiliaries, designs, develops, manufactures, and commercializes electric vehicles (EVs), EV parts, and off-road vehicles in the Peoples Republic of China and internationally.
During an Afternoon trade, Shares of Horizon Pharma PLC (NASDAQ:HZNP), dipped -2.56%, and is now trading at $30.47.
Horizon Pharma, declared the issuance of a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for U.S. patent application number 14/515,627 (U.S. publication number 2015-0125524), entitled “Pharmaceutical Compositions for the Coordinated Delivery of NSAIDs” that covers the U.S. approved medicine VIMOVO delayed release tablets.
This Notice of Allowance concludes the substantive examination of the patent application and will result in the issuance of a U.S. patent after administrative processes are accomplished. The U.S. patent planned to issue from this application will expire in 2022. After issuance, Horizon and POZEN Inc. plan to list the patent in the FDA’s Approved Drug Products with Therapeutic Equivalence Evaluations, or Orange Book. This will be the twelfth U.S. patent to be listed in the Orange Book for VIMOVO.
Horizon Pharma plc, a specialty biopharmaceutical company, engages in identifying, developing, acquiring or in-licensing, and commercializing medicines for the treatment of arthritis, pain, inflammatory, and/or orphan diseases in the United States and internationally.
Shares of Merge Healthcare Inc. (NASDAQ:MRGE), during its Thursday’s current trading session gained 0.07%, and is now trading at $7.09.
Merge Healthcare Incorporated, recognized as a top vendor in the KLAS 2015 Midterm Performance Review: Software & Services report. Merge Healthcare ranked second in the Software Performance by Vendor category, receiving an overall score of 81.9.
“At Merge, our dedication to assisting clients move their quality of care forward is at the foundation of what we do, and being recognized by KLAS is a testament to that commitment,” said Justin Dearborn, chief executive officer of Merge Healthcare. “We strive to deliver products that exceed our clients’ evolving needs so they are best prepared for success now and in the future. It is exciting to see our efforts translating into tangible achievements such as this.”
Merge Healthcare Incorporated develops software solutions that facilitate the sharing of images to create an electronic healthcare experience for patients and physicians worldwide. It operates in two segments, Merge Healthcare and Merge DNA.
Finally, Fastenal Company (NASDAQ:FAST), lost -1.12% Thursday.
Earlier this summer Fastenal, installed an additional FAST Solutions(R) industrial vending machine within the Terex(R) Mixer manufacturing plant in Fort Wayne, Indiana. Given how many vending devices (machines and lockers) Fastenal installs during a typical business day, it was a commonplace event … except in one regard: that particular machine represented the 50,000th FAST Solutions device conpresently installed at Fastenal customer sites worldwide.
This milestone would have seemed unthinkable in 2008 when Fastenal displayed two prototype machines at its annual customer expo, signaling the debut of its vending program. At the time, industrial vending (dispensing high-demand shop consumables at the point of use) was still very much a niche technology, mainly due to the high cost of the machines and the labor required to manage them. The breakthrough was Fastenal’s ability to provide machines and lockers as part of a low-cost, full-service inventory administration solution, leveraging its network of 2,600-plus stores to keep the devices continually filled with the right supplies to meet customers’ changing needs.
“From the starting, we saw vending as an investment in our customers — a way to solidify relationships and earn opportunities by providing tremendous value in terms of time and cost savings,” said Lee Hein, Fastenal’s chief operating officer. “It’s been a perfect fit for our local service model, bringing our store teams and products even closer to our customers.”
Fastenal Company, together with its auxiliaries, engages in the wholesale distribution of industrial and construction supplies in the United States, Canada, and internationally. The company offers fasteners, and other industrial and construction supplies primarily under the Fastenal name.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
